A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders

被引:0
作者
Oluwadara Pelumi Omotayo
Yolandy Lemmer
Shayne Mason
机构
[1] North-West University,Human Metabolomics, Faculty of Natural and Agricultural Sciences
[2] Next Generation Health,Council for Scientific and Industrial Research (CSIR)
[3] North-West University,Preclinical Drug Development Platform, Faculty of Health Sciences
来源
Journal of Cannabis Research | / 6卷
关键词
Anti-inflammatory cytokines; Cannabidiol (CBD); Neuroinflammation; Neurological infections; Neurological/neuropsychiatric disorders; Proinflammatory cytokines;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 960 条
[1]  
Abame MA(2021)Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus Neurosci Lett 744 135594-15
[2]  
He Y(2022)Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli Sci Reports 12 1-658
[3]  
Wu S(2008)Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets Ped Res 64 653-14
[4]  
Xie Z(2021)Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages Sci Reports 11 1-258
[5]  
Zhang J(2022)High-CBD extract (CBD-X) downregulates cytokine storm systemically and locally in inflamed lungs Front. Immunol 13 2252-269
[6]  
Gong X(2019)Antioxidative and anti-inflammatory properties of cannabidiol Anti 9 21-359
[7]  
Wu C(2012)Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol Rev 64 238-246
[8]  
Shen J(2022)Cannabinoids as immune system modulators: cannabidiol potential therapeutic approaches and limitations Cannabis and Cannabinoid Research. 8 254-1178
[9]  
Abichabki N(2022)Cannabinoids as immune system modulators: cannabidiol potential therapeutic approaches and limitations Cannabis Cannabinoid Res 8 254-852
[10]  
Zacharias LV(2023)Cannabidiol as a treatment for neurobiological, behavioral, and psychological symptoms in early-stage dementia: a double-blind, placebo-controlled clinical trial protocol Cannabis Cannabinoid Res 8 348-18